The history of oncology is rife with reports of patients with advanced cancer who staged miraculous recoveries.
Aiming deep inside the brain, drugmakers are testing medicines that may improve learning in people with Down syndrome, an advance unimaginable 50 years ago when many children with the genetic condition were considered hopelessly disabled.
Louis V. Gerstner III, the son of the executive credited with saving International Business Machines Corp., has died. He was 41.
When stock and bond markets took a dive in late January, hedge-fund manager David Ford kept his cool.